Skip to main content

Advertisement

Log in

Validation of the Italian version of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS)

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

An Erratum to this article was published on 31 December 2014

Abstract

Cognitive impairment (CI) is a frequent feature associated with both early and advanced stages of Parkinson’s disease (PD). An evaluation of cognitive functions is relevant to identify those parkinsonians at risk of developing dementia. In the present study, the Italian version of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) assessing fronto-subcortical and cortical cognitive functions in PD was validated in 387 parkinsonians and was used to test the empirical validity of the item 1.1 (cognitive impairment) of the Italian version of MDS-UPDRS as screening tool for CI in PD. PD-CRS was free from floor and ceiling effect. The mean PD-CRS score was 76.1 (mean cortical score, 24.5 ± 4.6; mean subcortical score, 51.5 ± 17.5). The internal consistency was satisfactory (α = 0.89); corrected item-total correlation was 0.570 (naming) to 0.696 (working memory). The correlation between PD-CRS and part I–IV of MDS-UPDRS was weak. The low agreement between classification of PD sample into patients with mild cognitive impairment (PD-MCI), dementia (PD-D) and normal cognition (PD-NC) according to scores of item 1.1 and classification according to cutoff scores of PD-CRS for PD-MCI, PD-D and PD-NC indicated a poor empirical validity of item 1.1 of MDS-UPDRS as cognitive screening tool for CI in PD (Κ = 0.114; weighted Κ = 0.17; SE of Κ = 0.038; 95 % confidence interval from 0.040 to 0.1895). The Italian version of PD-CRS is an easy, consistent and valid tool for assessment of the cognitive cortical and subcortical impairments in PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson’s disease. Mov Disord 26:2483–2495

    Article  PubMed  Google Scholar 

  2. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062–1069

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958–2969

    Article  PubMed  Google Scholar 

  4. Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A (2008) Parkinson’s disease-cognitive rating scale: a new cognitive scale specific for Parkinson’s disease. Mov Disord 23:998–1005

    Article  PubMed  Google Scholar 

  5. Antonini A, Abbruzzese G, Ferini-Strambi L, Tilley B, Huang J, Stebbins GT, Goetz CG, Barone P, Bandettini di Poggio M, Fabbrini G, Di Stasio F, Tinazzi M, Bovi T, Ramat S, Meoni S, Pezzoli G, Canesi M, Martinelli P, Maria Scaglione CL, Rossi A, Tambasco N, Santangelo G, Picillo M, Morgante L, Morgante F, Quatrale R, Sensi M, Pilleri M, Biundo R, Nordera G, Caria A, Pacchetti C, Zangaglia R, Lopiano L, Zibetti M, Zappia M, Nicoletti A, Quattrone A, Salsone M, Cossu G, Murgia D, Albanese A, Del Sorbo F, MDS-UPDRS Italian Validation Study Group (2012) Validation of the Italian version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale. Neurol Sci 34(5):683–687. doi:10.1007/s10072-012-1112-z

    Article  PubMed  Google Scholar 

  6. Fahn S, Elton RL, UPDRS program members (1987) Unified Parkinsons Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinsons disease, vol 2. Macmillan Healthcare Information, Florham Park, pp 153–163

    Google Scholar 

  7. McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health surveys adequate? Qual Life Res 4:293–307

    Article  CAS  PubMed  Google Scholar 

  8. Hays RD, Anderson R, Revicki D (1993) Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 2:441–449

    Article  CAS  PubMed  Google Scholar 

  9. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334

    Article  Google Scholar 

  10. Scientific Advisory Committee of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11:193–205

    Article  Google Scholar 

  11. Nunnally JC, Bernstein IH (1994) Psychometric theory. McGraw-Hill, New York

    Google Scholar 

  12. Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Pascual-Sedano B, Campolongo A, Kulisevsky J (2013) Parkinson’s disease-cognitive rating scale: psychometrics for mild cognitive impairment. Mov Disord. doi:10.1002/mds.25568

    PubMed  Google Scholar 

  13. Martínez-Martín P, Prieto-Jurczynska C, Frades-Payo B (2009) Psychometric attributes of the Parkinson’s Disease-Cognitive Rating Scale. An independent validation study. Rev Neurol 49:393–398

    Google Scholar 

  14. Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81–S92

    PubMed  Google Scholar 

  15. Santangelo G, Vitale C, Trojano L, Longo K, Cozzolino A, Grossi D, Barone P (2009) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256:632–638

    Article  CAS  PubMed  Google Scholar 

  16. Santangelo G, Vitale C, Trojano L, Angrisano MG, Picillo M, Errico D, Agosti V, Grossi D, Barone P (2013) Subthreshold depression and subjective cognitive complaints in Parkinson’s disease. Eur J Neurol. doi:10.1111/ene.12219

    Google Scholar 

  17. Pappatà S, Santangelo G, Aarsland D, Vicidomini C, Longo K, Bronnick K, Amboni M, Erro R, Vitale C, Caprio MG, Pellecchia MT, Brunetti A, De Michele G, Salvatore M, Barone P (2011) Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 77:1357–1362

    Article  PubMed  Google Scholar 

  18. Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson’s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11:697–707

    Article  PubMed  Google Scholar 

  19. Biundo R, Clabrese M, Weis L, Facchini S, Ricchieri G, Gallo P, Antonini A (2013) Anatomical correlates of cognitive functions in early Parkinson’s disease patients. PlosOne 8(5):e64222

    Article  Google Scholar 

Download references

Acknowledgment

This study has been funded by the Neureca Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Barone.

Additional information

On behalf of the IRIS Study Group.

Appendix: Investigators of IRIS Study Group

Appendix: Investigators of IRIS Study Group

Monica Bandettini di Poggio: Department of Neurosciences, Ophthalmology and Genetics, Centre for Movement Disorders, University of Genoa, Genoa, Italy.

Giovanni Fabbrini: Department of Neurology and Psychiatry, Sapienza University of Rome.

Flavio Di Stasio: Department of Neurology and Psychiatry, Sapienza University of Rome.

Michele Tinazzi:Dipartimento di Scienze Neurologiche, Neuropsicologiche, Morfologiche e Motorie, Universita` di Verona.

Tommaso Bovi: Dipartimento di Scienze Neurologiche, Neuropsicologiche, Morfologiche e Motorie, Universita` di Verona.

Silvia Ramat: Department of Neurosciences, University of Florence.

Sara Meoni: Department of Neurosciences, University of Florence.

Gianni Pezzoli: Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy.

Chiara Siri: Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy.

Margherita Canesi: Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy.

Paolo Martinelli: Dipartimento Scienze Neurologiche Universita` di Bologna Italy.

Cesa Lorella Maria Scaglione: Dipartimento Scienze Neurologiche Universita` di Bologna Italy.

Aroldo Rossi: Azienda Ospedaliera––Universita` di Perugia, Perugia (Italy).

Nicola Tambasco: Azienda Ospedaliera––Universita` di Perugia, Perugia (Italy).

Marina Picillo: Dipartimento di Scienze Neurologiche, Università Federico II, Napoli.

Letterio Morgante: Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Universita’ di Messina.

Francesca Morgante: Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Universita’ di Messina.

Rocco Quatrale: Neurology Unit University Hospital S. Annna Ferrara, Italy.

MariaChiara Sensi: Neurology Unit University Hospital S. Annna Ferrara, Italy.

Manuela Pilleri: Department for Parkinson disease, IRCCS San Camillo Venezia.

Roberta Biundo: Department for Parkinson disease, IRCCS San Camillo Venezia.

Giampietro Nordera: Casa di Cura Villa Margherita, Arcugnano (Vicenza) Italy.

Antonella Caria: Casa di Cura Villa Margherita, Arcugnano (Vicenza) Italy.

Claudio Pacchetti: Parkinson’s Dis. and Mov. Dis. Unit, Fondazione Istituto Neurologico Nazionale “C. Mondino”, IRCCS.

Roberta Zangaglia: Parkinson’s Dis. and Mov. Dis. Unit, Fondazione Istituto Neurologico Nazionale “C. Mondino”, IRCCS.

Leonardo Lopiano: Universita` degli Studi di Torino, Dipartimento di Neuroscienze, SCDU Neurologia 4.

Maurizio Zibetti: Universita` degli Studi di Torino, Dipartimento di Neuroscienze, SCDU Neurologia 4.

Mario Zappia: Dipartimento di Neuroscienze U.O.C. di Neurologia––Clinica Neurologica dell’Universita` degli Studi di Catania, Catania (Italy).

Alessandra Nicoletti: Dipartimento di Neuroscienze U.O.C. di Neurologia Clinica Neurologica dell’Universita` degli Studi di Catania, Catania (Italy).

Aldo Quattrone: Dipartimento di Scienze Mediche dell’Universita` degli Studi Magna Graecia, Catanzaro.

Maria Salsone: Dipartimento di Scienze Mediche dell’Universita` degli Studi Magna Graecia, Catanzaro.

Gianni Cossu: S. C. di Neurologia––A. O. “G. Brotzu” Cagliari.

Daniela Murgia: S. C. di Neurologia––A. O. “G. Brotzu” Cagliari.

Alberto Albanese: Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano.

Francesca Del Sorbo: Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santangelo, G., Barone, P., Abbruzzese, G. et al. Validation of the Italian version of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS). Neurol Sci 35, 537–544 (2014). https://doi.org/10.1007/s10072-013-1538-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-013-1538-y

Keywords

Navigation